Gang Bao

Molecular Biology · Nucleic Acids Research · 2013–2018

A researcher in the Science corpus: 7 papers; trusts 10 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 175 citations into it; #13,291 of 17,773 by trust here, #2,170 by citations

Whom Gang Bao trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Yanfang Fu
2. P. Mali
3. Thomas J. Cradick

Who trusts Gang Bao overall

1. Thomas J. Cradick
2. Ciaran M. Lee

Papers from Gang Bao's perspective

Ordered by how strongly the researchers Gang Bao trusts endorse each paper. Same corpus, a different order for every researcher.

1. Multiplex Genome Engineering Using CRISPR/Cas Systems
2. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases (Nature Biotechnology)
3. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity (Nature Biotechnology)
4. CRISPR-assisted editing of bacterial genomes (Nature Biotechnology)
5. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases (Genome Research)
6. Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria (Proceedings of the National Academy of Sciences of the United States of America)
7. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
8. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia
9. Knockout Rats Produced Using Designed Zinc Finger Nucleases (Science)
10. CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences (Nucleic Acids Research)

Their papers

• DNA targeting specificity of RNA-guided Cas9 nucleases (2013) — 4,640 citations
• CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences (2014) — 620 citations
• CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity (2013) — 629 citations
• A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human haematopoietic stem and progenitor cells (2018) — 671 citations
• COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites (2014) — 377 citations
• The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells (2016) — 224 citations
• Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human Genome. (2016) — 233 citations